Research Article
BibTex RIS Cite

Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study

Year 2023, Volume: 40 Issue: 3, 619 - 621, 30.09.2023

İsmail Büyükceran Şafak Aydın Şimşek Oğuzhan Muslu Tolgahan Cengiz Hüseyin Sina Coşkun Nevzat Dabak

Abstract

Tumors of hematopoietic origin are rare tumors that can be confused with benign and malignant tumors of the bone with their clinical and morphological features. Plasma cell myeloma, solitary plasmacytoma, Non-Hodgkin Lymphoma, acute lymphoblastic leukemia/lymphoma, and Langerhans cell histiocytosis are hematological neoplasms that mainly involve the bone. Plasma cell myeloma is the most common primary malignant bone neoplasm, and diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma arising in bone. In this case report, we will retrospectively investigate the diagnosis and treatment management and postoperative clinical outcomes of patients diagnosed with tumors of hematopoietic origin, evaluated by the Bone and Soft Tissue Tumor Council between 2005 and 2021, and emphasize the importance of the approach to these tumors.

Keywords

hematopoetic myelodysplasia multiple myeloma bone neoplasms leukemia

References

  • 1. Kim SH, Smith SE, Mulligan ME. Hematopoietic tumors and metastases involving bone. Radiologic Clinics. 2011;49(6):1163-83.
  • 2. Cleven AHG, Hogendoorn PCW. Hematopoietic Tumors Primarily Presenting in Bone. Surgical Pathology Clinics. 2017;10(3):675-91. doi https://doi.org/10.1016/j.path.2017.04.011.
  • 3. Zajączkowska R, Kocot-Kępska M, Leppert W, Wordliczek J. Bone Pain in Cancer Patients: Mechanisms and Current Treatment. International journal of molecular sciences. 2019;20(23). Epub 2019/12/06. doi: 10.3390/ijms20236047. PubMed PMID: 31801267; PubMed Central PMCID: PMCPMC6928918.
  • 4. Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet (London, England). 2015;385(9983):2197-208. Epub 2014/12/30. doi: 10.1016/s0140-6736(14)60493-1. PubMed PMID: 25540889.
  • 5. Mendenhall WM, Mendenhall CM, Mendenhall NP. Solitary plasmacytoma of bone and soft tissues. American Journal of otolaryngology. 2003;24(6):395-9. Epub 2003/11/11. doi: 10.1016/s0196-0709(03)00092-9. PubMed PMID: 14608572.
  • 6. Hernandez E, Rowan R, Randall M. A Case of Extranodal Metastasis of Primary Bone Lymphoma in the Lower Extremity. Journal of the American Podiatric Medical Association. 2018;108(1):52-7. Epub 2018/03/17. doi: 10.7547/15-115. PubMed PMID: 29547041.
  • 7. Lin P, Huang RF, Xie RT, Zhang YL, Zhuang WH, Zhang XY. [The Types and Laboratory Characteristics of Non-Hodgkin Lymphoma with Bone Marrow Invasion as the First Manifestation]. Zhongguo shi yan xue ye xue za zhi. 2021;29(4):1148-55. Epub 2021/08/08. doi: 10.19746/j.cnki.issn.1009-2137.2021.04.020. PubMed PMID: 34362495.
  • 8. Reisi N, Raeissi P, Harati Khalilabad T, Moafi A. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature. Orphanet J Rare Dis. 2021;16(1):1. Epub 2021/01/04. doi: 10.1186/s13023-020-01625-z. PubMed PMID: 33388073; PubMed Central PMCID: PMCPMC7778820.
  • 9. Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. Bone metastases. Nature reviews Disease primers. 2020;6(1):83. Epub 2020/10/17. doi: 10.1038/s41572-020-00216-3. PubMed PMID: 33060614.
  • 10. Reich CD. Advances in the treatment of bone metastases. Clinical journal of oncology nursing. 2003;7(6):641- 6. Epub 2004/01/07. doi: 10.1188/03.Cjon.641-646. PubMed PMID: 14705479.
  • 11. Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B. Bone metastases of unknown origin: epidemiology and principles of management. Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology. 2015;16(2):81-6. Epub 2015/03/03. doi: 10.1007/s10195-015-0344-0. PubMed PMID: 25726410; PubMed Central PMCID: PMCPMC4441638.

Year 2023, Volume: 40 Issue: 3, 619 - 621, 30.09.2023

İsmail Büyükceran Şafak Aydın Şimşek Oğuzhan Muslu Tolgahan Cengiz Hüseyin Sina Coşkun Nevzat Dabak

Abstract

References

  • 1. Kim SH, Smith SE, Mulligan ME. Hematopoietic tumors and metastases involving bone. Radiologic Clinics. 2011;49(6):1163-83.
  • 2. Cleven AHG, Hogendoorn PCW. Hematopoietic Tumors Primarily Presenting in Bone. Surgical Pathology Clinics. 2017;10(3):675-91. doi https://doi.org/10.1016/j.path.2017.04.011.
  • 3. Zajączkowska R, Kocot-Kępska M, Leppert W, Wordliczek J. Bone Pain in Cancer Patients: Mechanisms and Current Treatment. International journal of molecular sciences. 2019;20(23). Epub 2019/12/06. doi: 10.3390/ijms20236047. PubMed PMID: 31801267; PubMed Central PMCID: PMCPMC6928918.
  • 4. Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet (London, England). 2015;385(9983):2197-208. Epub 2014/12/30. doi: 10.1016/s0140-6736(14)60493-1. PubMed PMID: 25540889.
  • 5. Mendenhall WM, Mendenhall CM, Mendenhall NP. Solitary plasmacytoma of bone and soft tissues. American Journal of otolaryngology. 2003;24(6):395-9. Epub 2003/11/11. doi: 10.1016/s0196-0709(03)00092-9. PubMed PMID: 14608572.
  • 6. Hernandez E, Rowan R, Randall M. A Case of Extranodal Metastasis of Primary Bone Lymphoma in the Lower Extremity. Journal of the American Podiatric Medical Association. 2018;108(1):52-7. Epub 2018/03/17. doi: 10.7547/15-115. PubMed PMID: 29547041.
  • 7. Lin P, Huang RF, Xie RT, Zhang YL, Zhuang WH, Zhang XY. [The Types and Laboratory Characteristics of Non-Hodgkin Lymphoma with Bone Marrow Invasion as the First Manifestation]. Zhongguo shi yan xue ye xue za zhi. 2021;29(4):1148-55. Epub 2021/08/08. doi: 10.19746/j.cnki.issn.1009-2137.2021.04.020. PubMed PMID: 34362495.
  • 8. Reisi N, Raeissi P, Harati Khalilabad T, Moafi A. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature. Orphanet J Rare Dis. 2021;16(1):1. Epub 2021/01/04. doi: 10.1186/s13023-020-01625-z. PubMed PMID: 33388073; PubMed Central PMCID: PMCPMC7778820.
  • 9. Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. Bone metastases. Nature reviews Disease primers. 2020;6(1):83. Epub 2020/10/17. doi: 10.1038/s41572-020-00216-3. PubMed PMID: 33060614.
  • 10. Reich CD. Advances in the treatment of bone metastases. Clinical journal of oncology nursing. 2003;7(6):641- 6. Epub 2004/01/07. doi: 10.1188/03.Cjon.641-646. PubMed PMID: 14705479.
  • 11. Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B. Bone metastases of unknown origin: epidemiology and principles of management. Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology. 2015;16(2):81-6. Epub 2015/03/03. doi: 10.1007/s10195-015-0344-0. PubMed PMID: 25726410; PubMed Central PMCID: PMCPMC4441638.
There are 11 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Research Article
Authors

İsmail Büyükceran 0000-0002-9771-8654

Şafak Aydın Şimşek 0000-0003-2250-8043

Oğuzhan Muslu 0000-0001-8568-9625

Tolgahan Cengiz 0000-0003-2363-0198

Hüseyin Sina Coşkun 0000-0003-2965-3112

Nevzat Dabak 0000-0002-4591-7897

Early Pub Date October 6, 2023
Publication Date September 30, 2023
Submission Date April 10, 2023
Acceptance Date August 29, 2023
Published in Issue Year 2023 Volume: 40 Issue: 3

Cite

APA Büyükceran, İ., Aydın Şimşek, Ş., Muslu, O., Cengiz, T., et al. (2023). Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study. Journal of Experimental and Clinical Medicine, 40(3), 619-621.
AMA Büyükceran İ, Aydın Şimşek Ş, Muslu O, Cengiz T, Coşkun HS, Dabak N. Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study. J. Exp. Clin. Med. September 2023;40(3):619-621.
Chicago Büyükceran, İsmail, Şafak Aydın Şimşek, Oğuzhan Muslu, Tolgahan Cengiz, Hüseyin Sina Coşkun, and Nevzat Dabak. “Primary Malignant Bone Tumors of Hematopoietic Origin: A Single-Center Retrospective Study”. Journal of Experimental and Clinical Medicine 40, no. 3 (September 2023): 619-21.
EndNote Büyükceran İ, Aydın Şimşek Ş, Muslu O, Cengiz T, Coşkun HS, Dabak N (September 1, 2023) Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study. Journal of Experimental and Clinical Medicine 40 3 619–621.
IEEE İ. Büyükceran, Ş. Aydın Şimşek, O. Muslu, T. Cengiz, H. S. Coşkun, and N. Dabak, “Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study”, J. Exp. Clin. Med., vol. 40, no. 3, pp. 619–621, 2023.
ISNAD Büyükceran, İsmail et al. “Primary Malignant Bone Tumors of Hematopoietic Origin: A Single-Center Retrospective Study”. Journal of Experimental and Clinical Medicine 40/3 (September 2023), 619-621.
JAMA Büyükceran İ, Aydın Şimşek Ş, Muslu O, Cengiz T, Coşkun HS, Dabak N. Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study. J. Exp. Clin. Med. 2023;40:619–621.
MLA Büyükceran, İsmail et al. “Primary Malignant Bone Tumors of Hematopoietic Origin: A Single-Center Retrospective Study”. Journal of Experimental and Clinical Medicine, vol. 40, no. 3, 2023, pp. 619-21.
Vancouver Büyükceran İ, Aydın Şimşek Ş, Muslu O, Cengiz T, Coşkun HS, Dabak N. Primary malignant bone tumors of hematopoietic origin: A single-center retrospective study. J. Exp. Clin. Med. 2023;40(3):619-21.
 Download Cover Image

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.